ADA 2026 Recap: Days 1 and 2 Breakthrough T1DNewer GLP-1s, pushback on research cuts, and a protest statnews.comLilly and Novo face off at ADA 2026 as others seek to compete in obesity BioSpaceSpotlight On: Four things to watch at ADA 2026 FirstWord PharmaUS diabetes conference is set to scrutinize weight-loss drugs medwatch.com